AstraZeneca Pharma India Limited has received shareholder approval to shift its registered office from the State of Karnataka to the State of Maharashtra. This decision, finalized through a postal ballot and remote e-voting process, also includes a formal amendment to the company’s Memorandum of Association. The transition remains subject to pending regulatory approvals under the Companies Act, 2013.
Shareholder Approval Secured
Following a recent voting process, shareholders of AstraZeneca Pharma India Limited have officially authorized the relocation of the company’s registered office. The resolution to move operations from the State of Karnataka to the State of Maharashtra was passed via remote e-voting, with the results formally declared on May 11, 2026.
Amendment to Corporate Documents
As a direct result of this relocation, the company will amend the 2nd Clause of its Memorandum of Association (MOA). This change is a necessary legal step to reflect the shift in the company’s primary corporate jurisdiction.
Next Steps
While the internal mandate from shareholders has been secured, the move remains contingent upon receiving the necessary regulatory approvals. The company will proceed with these filings in accordance with the provisions of the Companies Act, 2013 and the associated governing rules to complete the transition process.
Source: BSE
